SG11201503777YA - Compositions and methods for the treatment of ectodermal dysplasia - Google Patents

Compositions and methods for the treatment of ectodermal dysplasia

Info

Publication number
SG11201503777YA
SG11201503777YA SG11201503777YA SG11201503777YA SG11201503777YA SG 11201503777Y A SG11201503777Y A SG 11201503777YA SG 11201503777Y A SG11201503777Y A SG 11201503777YA SG 11201503777Y A SG11201503777Y A SG 11201503777YA SG 11201503777Y A SG11201503777Y A SG 11201503777YA
Authority
SG
Singapore
Prior art keywords
compositions
treatment
methods
ectodermal dysplasia
ectodermal
Prior art date
Application number
SG11201503777YA
Other languages
English (en)
Inventor
Kenneth M Huttner
Neil Kirby
Pascal Schneider
Olivier Gaide
Original Assignee
Edimer Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edimer Pharmaceuticals Inc filed Critical Edimer Pharmaceuticals Inc
Publication of SG11201503777YA publication Critical patent/SG11201503777YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201503777YA 2012-11-14 2013-11-13 Compositions and methods for the treatment of ectodermal dysplasia SG11201503777YA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261726252P 2012-11-14 2012-11-14
US201361825227P 2013-05-20 2013-05-20
PCT/US2013/069799 WO2014078353A1 (en) 2012-11-14 2013-11-13 Compositions and methods for the treatment of ectodermal dysplasia

Publications (1)

Publication Number Publication Date
SG11201503777YA true SG11201503777YA (en) 2015-06-29

Family

ID=50731641

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201503777YA SG11201503777YA (en) 2012-11-14 2013-11-13 Compositions and methods for the treatment of ectodermal dysplasia

Country Status (14)

Country Link
US (1) US20160272694A1 (es)
EP (1) EP2920318A4 (es)
JP (1) JP2015536344A (es)
KR (1) KR20150099720A (es)
AR (1) AR093476A1 (es)
AU (1) AU2013344973B2 (es)
BR (1) BR112015011099A2 (es)
CA (1) CA2891386A1 (es)
IL (1) IL238602A0 (es)
MX (1) MX2015005993A (es)
RU (1) RU2015117995A (es)
SG (1) SG11201503777YA (es)
TW (1) TW201438730A (es)
WO (1) WO2014078353A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10300013B2 (en) 2013-10-22 2019-05-28 Espoirxlhed Sàrl Intra-amniotic administration of EDI200 for the treatment of ectodermal dysplasias
JP2020154180A (ja) * 2019-03-20 2020-09-24 ヤフー株式会社 情報処理装置、情報処理方法および情報処理プログラム
JP2020154178A (ja) * 2019-03-20 2020-09-24 ヤフー株式会社 情報処理装置、情報処理方法および情報処理プログラム
JP2020154179A (ja) * 2019-03-20 2020-09-24 ヤフー株式会社 情報処理装置、情報処理方法および情報処理プログラム
CN114145452B (zh) * 2021-12-10 2022-11-01 青岛圣桐营养食品有限公司 特殊医学用途全营养配方食品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506569B1 (en) * 1997-05-30 2003-01-14 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor TR10
WO2003068977A2 (de) * 2002-02-10 2003-08-21 Apoxis Sa Fusionkonstrukte, enthaltend aktive abschnitte von tnf-liganden
EP2697258B1 (en) * 2011-05-13 2017-02-01 Edimer Pharmaceuticals, Inc. Compositions and methods for the alteration of xlhed phenotypes

Also Published As

Publication number Publication date
AU2013344973B2 (en) 2016-10-06
IL238602A0 (en) 2015-06-30
US20160272694A1 (en) 2016-09-22
AU2013344973A1 (en) 2015-05-14
CA2891386A1 (en) 2014-05-22
AR093476A1 (es) 2015-06-10
EP2920318A1 (en) 2015-09-23
WO2014078353A1 (en) 2014-05-22
TW201438730A (zh) 2014-10-16
MX2015005993A (es) 2015-12-09
BR112015011099A2 (pt) 2017-08-22
EP2920318A4 (en) 2016-04-13
RU2015117995A (ru) 2017-01-10
KR20150099720A (ko) 2015-09-01
JP2015536344A (ja) 2015-12-21

Similar Documents

Publication Publication Date Title
IL266582A (en) Preparations and methods for the treatment of hemoglobin diseases
HK1210957A1 (en) Effluz inhibitor compositions and methods of treatment using the same
HK1215785A1 (zh) 控制釋放組合物及使用方法
EP2736528A4 (en) COMPOSITIONS AND METHODS OF TREATING HIV
IL238177A0 (en) Methods and preparations for the treatment of cancer
EP2688594A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
ZA201408056B (en) Compositions and methods for the treatment of mucositis
DK3292875T3 (en) Compositions and methods for treating diseases
EP2858648A4 (en) METHODS AND COMPOSITIONS FOR INHIBITING PIN1
HK1224210A1 (zh) 用於治療纖維化的方法和組合物
ZA201408055B (en) Compositions and methods for the treatment of local pain
IL238602A0 (en) Preparations and methods for the treatment of ectodermal dysplasia
HK1220374A1 (zh) 用於治療碳氧血紅蛋白血症的組合物和方法
ZA201408062B (en) Compositions and methods for the treatment of multiple sclerosis
EP2852370A4 (en) FLASH-CONTAINING COMPOSITIONS AND METHODS OF USE
ZA201406267B (en) Controlled release compositions and their methods of use
EP2928456A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP2800568A4 (en) COMPOSITIONS, USE METHOD AND TREATMENT METHOD THEREFOR
ZA201408058B (en) Compositions and methods for the treatment of epilepsy
EP2841164A4 (en) COMPOSITIONS AND USE PROCEDURES FOR THE SKIN